Drug Research
Croda announces two new partnerships to drive sustainable delivery systems for the pharmaceutical industry
Croda International Plc (Croda) announced that it has signed two new partnership agreements that will help the pharmaceutical industry move towards a more sustainable supply chain for vaccine adjuvants.
The first partnership is an exclusive license agreement with Amyris, a...
Drug Research
Sygnature Discovery launches its LPS in vivo model to profile early – stage anti-inflammatory drugs
Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets.
The LPS in vivo model supports...
News
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, will share a first look at industry research at the DIA Global Annual Meeting 2023.
CluePoints will host an exclusive opportunity for RBQM...
IT & Data Management
Paper To Pixels: Digital Transformation In Life Sciences
To gain a competitive advantage, organizations are proactively overhauling their digital transformation strategies. It has become evident that traditional paper-based operations and fragmented data collection methods limit their ability to adapt and thrive in the constantly shifting market. The...
Drug Research
Innovate UK – funded biotech company accelerates cheaper drug and vaccine manufacture after biocomputer breakthrough
An Innovate UK-backed biotech company has achieved a pioneering biocomputer breakthrough which is accelerating the development and manufacture of cheaper drugs and vaccines.
BiologIC Technologies, inventor of the world’s first biocomputer, has developed 3D printed ‘lab-on-a-chip’ platforms - miniaturised devices...
BioPharma
Cell And Gene Therapy CDMO Services Market Is On The Rise
The global cell and gene therapy Contract Development and Manufacturing Organization (CDMO) services market, which was valued at USD 5,193.7 million in 2022, is expected to grow at a CAGR of 17.5% during the forecast period from 2023 to...
Drug Research
Rising Demand Fuels Asia Pacific Pharmaceutical CDMO Market
The Asia Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market is expected to see significant growth. Factors driving this include rising pharmaceutical demand, increased focus on research and development, and the outsourcing of drug development and manufacturing. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read